SWX:NESN
SWX:NESNFood

Is Nestlé’s (SWX:NESN) SMA Recall Quietly Testing The Foundations Of Its Infant Nutrition Trust?

Nestlé recently recalled several batches of its SMA infant and follow-on formula in the UK after tests indicated potential cereulide toxin contamination, although no related illnesses have been confirmed to date. This incident puts a spotlight on Nestlé’s infant nutrition quality controls and brand trust, especially in a category where safety perceptions are critical. We’ll now examine how this precautionary SMA formula recall, and its implications for consumer trust, may influence Nestlé’s...
SWX:ALC
SWX:ALCMedical Equipment

Is Alcon (SWX:ALC) Offering Value After A 15% One Year Share Price Decline

Wondering whether Alcon’s current share price gives you fair value for your money, or if you are paying up for quality? This article breaks down what the numbers are actually saying about the stock. The shares recently closed at $64.64, with returns of 2.1% over the past week, 0.6% over the past month, 1.7% year to date, and a 15.0% decline over the last year, putting recent moves into a longer term context. These mixed returns have sharpened the focus on what is really priced into Alcon...
SWX:NOVN
SWX:NOVNPharmaceuticals

Assessing Novartis (SWX:NOVN) Valuation After Strong Multi‑Year Shareholder Returns

Novartis (SWX:NOVN) shares have quietly moved higher over the past month and past 3 months, putting recent performance and current valuation metrics in focus for investors watching this large Swiss pharmaceutical group. See our latest analysis for Novartis. Zooming out, the share price is at CHF 111.52 with a 1 year total shareholder return of 27.79% and a 5 year total shareholder return of 71.01%, suggesting momentum has been building rather than fading over time. If Novartis has you...
SWX:NESN
SWX:NESNFood

Assessing Nestlé (SWX:NESN) Valuation After Recent Mixed Returns And Longer Term Momentum Weakness

Nestlé (SWX:NESN) is back in focus after recent share price moves, with the stock showing mixed short term returns and a modestly positive performance over the past 3 months, prompting fresh questions about how its current valuation stacks up. See our latest analysis for Nestlé. At a share price of CHF 76.16, Nestlé’s short term share price returns have been weak, while its 1 year total shareholder return of 5.3% contrasts with deeper three and five year total return declines. This points to...
SWX:MOLN
SWX:MOLNBiotechs

Betolar Oyj And 2 Other European Penny Stocks Worth Watching

European markets have shown robust performance, with the pan-European STOXX Europe 600 Index reaching a new high and closing 2025 with its strongest annual return since 2021. For investors interested in smaller or newer companies, penny stocks—despite their somewhat outdated name—remain a relevant investment area. These stocks can offer surprising value when backed by strong financials, presenting opportunities for growth that larger firms might miss.
SWX:MOBN
SWX:MOBNReal Estate

Mobimo’s Moody’s-Endorsed Green Bond Could Be A Game Changer For Mobimo Holding (SWX:MOBN)

Mobimo Holding AG recently placed a CHF 155 million green bond on the Swiss capital market under its new Green Financing Framework, with listing on the Swiss Exchange planned from 28 January 2026. The bond, backed by a positive Second Party Opinion from Moody’s Ratings for alignment with international green finance principles, highlights Mobimo’s growing appeal to environmentally focused investors in the Swiss real estate space. Next, we’ll explore how this Moody’s-endorsed Green Financing...
SWX:ROG
SWX:ROGPharmaceuticals

Is Roche Holding (SWX:ROG) Still Attractive After Its Strong Multi Year Share Price Run?

Wondering if Roche Holding is still a sensible entry point after a strong run, or if the easy money has already been made? This article is built to help you think clearly about what you might be paying for today. The stock last closed at CHF 329.90, with returns of 0.5% over 7 days, 6.1% over 30 days, 1.4% year to date, 28.9% over 1 year and 25.8% over 3 years, as well as 23.9% over 5 years. This raises fair questions about how expectations and perceived risk are now priced in. Recent news...
SWX:IDIA
SWX:IDIABiotechs

Assessing Idorsia (SWX:IDIA) Valuation After Recent Share Price Volatility

Idorsia (SWX:IDIA) has drawn investor attention after recent share price swings, with the stock closing at CHF 3.70. With mixed short term returns and a low value score of 2, fundamentals are under closer scrutiny. See our latest analysis for Idorsia. The recent 1 day share price return of an 8.87% decline to CHF 3.70 extends a softer trend, with a 7 day share price return of a 13.04% decline and a 90 day share price return of a 21.28% decline, even as the 1 year total shareholder return is...